Medirom Healthcare (MRM) | Stock Overview & Key Data
Medirom Healthcare Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: $19.80 on December 28, 2020
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Financial Highlights
Annual Income Flow
2024
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 9.25M Micro-cap | -0.83% | -2.46% | -9.16% | -44.13% | -39.29% | -26.45% | -81.00% | -89.30% | -92.08% | -92.08% | -92.08% | |
|
Rollins
ROL
|
27.47B Large-cap | -5.91% | -14.13% | -19.83% | -22.94% | -21.20% | -16.86% | 17.15% | 43.42% | 273.33% | 736.56% | 1,730.77% |
|
Service
SCI
|
11.76B Large-cap | -8.49% | -11.25% | -14.88% | -8.17% | -9.57% | -3.60% | 16.32% | 41.98% | 175.12% | 575.56% | 835.20% |
|
Medifast
MED
|
121.13M Micro-cap | -6.69% | 15.43% | 14.57% | 12.98% | 17.98% | -10.95% | -85.01% | -95.99% | -61.95% | -51.02% | -36.36% |
| 92.67M Micro-cap | 0.94% | 58.20% | -25.18% | -33.41% | -45.10% | 6,292.31% | 131.15% | -58.43% | 9.85% | -78.19% | -60.76% | |
|
Regis
RGS
|
67.69M Micro-cap | -5.83% | 3.23% | 23.32% | -5.15% | 2.66% | 29.78% | 28.36% | -84.83% | -88.92% | 97.62% | -19.75% |
Ownership & Short Interest
Calculate Your Medirom Healthcare Investment Returns
Long-Term Investment Performance Analysis
Medirom Healthcare stock price in Dec 2020 was $14.40, A $1,000.00 lump sum investment in Medirom Healthcare made 5 years ago would be worth approximately $82.64 today, representing a negative return of -91.74%. This translates to an annualized return (CAGR) of -36.81%.
5 Years 5 Months Investment Scenario (Dec 2020 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is MRM's 52-week high and low?
- In the last 52 weeks, Medirom Healthcare reached a high of $4.45 (on September 26, 2025) and a low of $0.90 (on May 20, 2026).
- What is the market cap and P/E ratio for MRM?
- Curious about Medirom Healthcare's size and valuation? Its market capitalization stands at 9.25M. When it comes to valuation, the P/E ratio (trailing twelve months) is 3.09, and the forward P/E (looking ahead) is N/A.
- Does MRM pay dividends? If so, what's the yield?
- As for dividends, Medirom Healthcare isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Medirom Healthcare's main competitors or similar companies to consider before investing?
When looking at Medirom Healthcare, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Rollins
ROL27.47B Consumer Cyclical Personal Services -16.86% 17.15% Service
SCI11.76B Consumer Cyclical Personal Services -3.60% 16.32% Medifast
MED121.13M Consumer Cyclical Personal Services -10.95% -85.01% WW International
WW92.67M Consumer Cyclical Personal Services 6,292.31% 131.15% Regis
RGS67.69M Consumer Cyclical Personal Services 29.78% 28.36% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Medirom Healthcare Technologies Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of Medirom Healthcare's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 53.19%, the Debt to Equity ratio from the most recent quarter is 786.42, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for MRM?
- Looking at Medirom Healthcare's growth, its revenue over the trailing twelve months (TTM) was $51M. Compared to the same quarter last year (YoY), quarterly revenue grew by -6.70%, and quarterly earnings saw a YoY growth of N/A.
- How much of MRM stock is held by insiders and institutions?
- Wondering who owns Medirom Healthcare stock? Company insiders (like executives and directors) hold about 26.42% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 0.18%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.